Stock INCR INTERCURE LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

InterCure Ltd. TEL AVIV STOCK EXCHANGE

Equities

INCR

IL0011063760

Healthcare Facilities & Services

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about InterCure Ltd.

InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023 CI
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months CI
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations CI
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million. CI
InterCure Ltd.(TASE:INCR) dropped from S&P Global BMI Index CI
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Intercure to Delist Its Shares From the Toronto Stock Exchange MT
InterCure Provides Update About Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger MT
Transcript : InterCure Ltd., 2022 Earnings Call, Apr 04, 2023
InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd. CI
InterCure to Launch Trading on Nasdaq Wednesday MT
InterCure Ltd. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
InterCure Provided Update on Its NASDAQ Listing MT
InterCure Ltd signed a Letter of Intent to acquire Cann Pharmaceutical Ltd. for $35 million. CI
InterCure : Israel's Canndoc signs cannabis import-export deal with Tilray RE
Regenera Pharma Ltd. announced that it expects to receive funding from InterCure Ltd. and other investors CI
InterCure Ltd. announced that it has received ILS 1.5 million in funding CI
InterCure Ltd. announced that it expects to receive ILS 1.5 million in funding CI
InterCure Ltd. completed the acquisition of additional 7.43% stake in Regenera Pharma Ltd. from Bamot Investments Ltd. CI
InterCure Ltd. signed an agreement to acquire additional 7.43% stake in Regenera Pharma Ltd. from Bamot Investments Ltd. for ILS 3 million. CI
Novellusdx Ltd. announced that it has received $12.5 million in funding from Pontifax Ltd., InterCure Ltd., OrbiMed Advisors, L.L.C. CI

Chart InterCure Ltd.

Chart InterCure Ltd.
More charts

Company Profile

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Sector
Healthcare Facilities & Services
Calendar
2024-05-12 - Q1 2024 Earnings Release (Projected)
More about the company

Sector Medical Farming

1st Jan change Capi.
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+54.73% 300M
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+34.02% 276M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+47.09% 189M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+52.50% 138M
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-32.30% 139M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
+7.69% 92.72M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-42.86% 95.85M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
GOLD FLORA CORPORATION Stock Gold Flora Corporation
+43.75% 66.15M
Medical Farming
  1. Stock Market
  2. Equities
  3. INCR Stock
  4. INCR Stock
  5. News InterCure Ltd.
  6. InterCure : Details Record Preliminary Q3 Revs of C$24 million, Three Times YoY and 36% QoQ Growth